A B S T R A C T Spontaneous and chemically induced mutants with reduced ability to produce cholera enterotoxin (choleragen) as an extracellular protein were isolated from Vibrio cholerae strains 569B Inaba, a classical cholera vibrio, and 3083-2 Ogawa, an El Tor vibrio. By qualitative and quantitative immunological assays in vitro such mutants could be separated into different classes characterized either by production of no detectable choleragen (tox), or of small quantities of extracellular choleragen, or of large quantities of cell-associated choleragen but little extracellular choleragen. Analysis of proteins in concentrated culture supernates by electrophoresis in polyacrylamide gels showed that cultures from tox-strains lacked proteins with electrophoretic mobilities corresponding with choleragen or the spontaneously formed toxoid (choleragenoid). Infant rabbits infected with the tox-strains remained asymptomatic or developed milder symptoms than rabbits infected with the tox+ parental strains. When symptoms of cholera developed after inoculation with tox-mutants, detectable numbers of tox+ revertants could be isolated from the intestines of the infected animals. Two toxt strains, designated M13 and M27, caused no symptoms and showed no evidence of reversion to tox+ during single passage in infant rabbits, and mutant M13 also remained avirulent and stably tox-during six cycles of serial passage in infant rabbits. Strains M13 and M27 were also noncholeragenic in adult rabbit ileal loops. Quantitative cultures of the intestines from infected inPortions of this work were presented at the 73rd Annual Meeting of the American Society for Microbiology, Miami Beach, Fla., May 1973, and at the 9th Joint Conference on Cholera, the United States-Japan Cooperative Medical Science Program, Grand Canyon, Ariz., October 1973. Received for publication 3 September 1974 and in revised form 4 November 1974. fant rabbits demonstrated that the avirulent mutant M13 can multiply in vivo and can persist in the intestinal tract for at least 48 h.
INTRODUCTION
Cholera enterotoxin (choleragen) is an extracellular protein of Vibrio cholerae that has been purified to homogeneity (1) , crystallized (2) , and studied extensively in many laboratories (3) . When purified choleragen is administered into the lumen of the small intestine of susceptible animals, it elicits a secretory response resulting in profuse diarrhea that mimics the symptoms of cholera in man (4) . Choleragen binds to specific receptors, identical or similar to the ganglioside designated Gm1 or GGnSLC, in the plasma membrane of mammalian cells (5, 6) . This is followed by activation of adenylate cyclase, leading to an increase in the intracellular concentration of cyclic 3',5'-adenosine monophosphate (cyclic AMP) (7) (8) (9) . The biological activities of choleragen on the intestinal mucosa as well as on other target cells in man and in experimental animals are believed to be mediated by cyclic AMP (3) . Although other properties of V. cholerae may be important as determinants of virulence, the ability to produce enterotoxin is indispensable for choleragenicity (3, 10) .
Little information is available concerning the regulation of enterotoxin synthesis by V. cholerae, and the role of such regulatory mechanisms in the pathogenesis of cholera is unknown. Some enteropathogenic strains of Escherichia coli produce an enterotoxin that cross-reacts immunologically with choleragen (11) and resembles choleragen in its mode of action (12) . In such enterotoxigenic strains of E. coli the ent gene controlling enterotoxin production can be present on extrachromosomal genetic elements called plasmids (13) . Although a conjugal mating system has been discovered and has been exploited for genetic mapping of the chromosome of V. cholerae (14, 15) , the genes that determine enterotoxin production in V. cholerae have not yet been analyzed.
To begin studies on the genetic regulation of toxinogenesis in V. chlolerae, methods were developed for the isolation of nontoxinogenic mutants and for the differentiation of tox-from tox-bacterial strains by rapid immunological techniques based on precipitin reactions that can be scored visually (10, 16) . A collection of independently derived, nontoxinogenic mutants of V. cholerae has been isolated. In the present study these toxA mutants have been compared with the tox+ parental strains both in vitro and in two models of cholera in experimental animals, the intraintestinal infection of infant rabbits (17) , and the intraintestinal inoculation of ligated ileal loops in adult rabbits (18) .
METHODS
Bacterial strains. V. cholerae strain 569B Inaba is a classical cholera vibrio that produces large quantities of enterotoxin in vitro, and V. cholerae 3083-2 variant, hereafter designated 3083-2, is a toxinogenic Ogawa strain cf the El Tor biotype (10) . Ogawa and Inaba serotypes of parental and mutant strains of V. cholerae were determined by slide agglutination tests (19) .
Media and bacterial cultures. All bacterial strains were stored as lyophilized cultures. Syncase broth, meat extract agar, minimal agar, and antitoxin agar have been described previously (10) . Unless otherwise noted, all cultures were incubated at 370C and broth cultures were aerated by rotary shaking at 240 rpm. After rehydration of lyophilized cultures, samples were inoculated onto meat extract agar either for confluent growth or for single colony isolation. Liquid cultures in syncase broth were inoculated from single colonies when clones of cells were required for genetic experiments. Routine broth cultures were inoculated with specimens from plates with confluent bacterial growth. Broth cultures in sterile Erlenmeyer flasks plugged with gauze contained 10-ml vol in 125-ml flasks or 200-ml vol in 1-liter flasks. For production of enterotoxin, cultures were incubated at 30'C with reciprocal shaking as described previously (10) .
Viable bacteria in broth cultures or in homogenates of intestines from infected animals were enumerated by spreading aliquots of appropriately diluted specimens on the surface of meat extract agar and counting colonies that developed after incubation of the plates for 18 h.
Induction of mutations in V. cholerae and selection of nontoxinogenic mutants. The procedure used for mutagenesis with N-methyl-N'-nitro-N-nitrosoguanidine (NTG)' (Sigma Chemical Co., St. Louis, Mo.) was modified from the method of Adelberg, Mandel, and Chen (20) and has been described previously (10) . Mutagenesis with ethyl methanesulfonate (EMS) (Eastman Kodak Co., Rochester, N. Y.) was based on the method of Loveless and Howarth (21) . Exponentially growing cultures in 10 ml of syncase Abbreviations used in this pqper: EB, ethidium bromide; EMS, ethyl methanesulfonate; NTG, N-methyl-N'-nitro-N-nitrosoguanidine. broth containing 1.7 X 108 viable cells/ml were harvested by centrifugation, and the cells were resuspended in 3-ml vol of EMS and incubated at 370C for 15 min. After incubation, the mutagenized cells were washed by centrifugation three times in syncase broth and then resuspended in 10 ml of syncase broth and incubated overnight at 30'C with rotary shaking. As determined by viable counts performed before and immediately after incubation in EMS, approximately 16%o of the V. cholerae cells present initially survived treatment with EMS. Mutagenesis with ethidium bromide (EB) (Sigma Chemical Co.) was based on the method of Bouanchaud, Scavizzi, and Chabbert (22) . Exponentially growing cultures of V. cholerae in syncase broth were diluted in the same medium to a final concentration of 2 X 10' cells/ml, and EB was added at a concentration of 2.5 X 10' M, sufficient to inhibit growth slightly, or 1.0 X 10' M, a subinhibitory concentration. Cultures were incubated with agitation for 18 h. After each of the above mutagenic treatments, cultures were diluted appropriately and inoculated into pour plates containing antitoxin agar. In this medium colonies of the toxinogenic parental strains are surrounded by halos of toxin-antitoxin precipitate and can be differentiated visually from mutant colonies that lack halos (10) . Mutants of V. cholerae 569B with altered toxinogenicity were designated arbitrarily by the prefix M and numbered sequentially in order of isolation.
In vitro tests for production of enterotoxin by wild type and mutant strains of V. cholerae. Precipitin tests for cholera enterotoxin were carried out with cultures of cholera vibrios or were performed with antigens prepared either from extracellular products in cultures of V. cholerae or from cell-associated products obtained by disruption of washed bacterial cells. Cultivation of V. cholerae in pour plates containing antitoxin agar was found to be particularly useful for the recognition of totr-mutants in cultures (10) . When large numbers of bacterial strains must be checked for their ability to produce enterotoxin, Elek plates are more convenient than pour plates with antitoxin agar, because many cultures can be tested on a single Elek plate. In an Elek test, cultures are streaked on the surface of the agar at right angles to a strip of filter paper impregnated with antitoxin, and toxin-antitoxin precipitin lines form adjacent to growing bacteria that produce enterotoxin (16) . To detect enterotoxin released from bacterial cells into syncase broth, cells were removed from 18-h cultures by centrifugation, the supernates were sterilized by passage through 0.45-,tm filters (Millipore Corp., Bedford, Mass.) and the cell-free supernates were used as antigen after they were concentrated 20-or 100-fold by ultrafiltration with membrane filters (PM-10, Amicon Corp., Lexington, Mass.). To detect cell-associated enterotoxin, cells were collected by centrifugation from 200-ml vol of 18-h syncase broth cultures, suspended in 5-ml samples of syncase broth, maintained in an ice bath, and disrupted by sonication for 3-5 min with a Branson sonicator (Branson Instruments Co., Stamford, Conn.). Similar results were obtained in immunodiffusion assays for enterotoxin when disrupted cell preparations were used as antigen either before or after removal of cellular debris by centrifugation. Quantitative assays for choleragen by immunodiffusion in agar gels were based on the methods of Oakley and Fulthorpe (23) and of Mancini, Carbonara, and Heremans (24) , and qualitative immunodiffusion tests were modified from the procedure of Ouchterlony (25), as previously described (4, 10) . A highly specific equine anticholeragenoid antiserum was used throughout this study (26) . Choleragen and choleragenoid used as standards for immunodiffusion, for electrophoresis, and for other purposes throughout this study were purified by methods described previously (1, 10) . Biological assays for production of enterotoxin by V. cholerae. Strains of V. cholerae to be tested were grown in syncase broth to a cell density between 10' and 109 cells/ ml. Infant rabbits were infected at laparotomy by injection of 0.5 ml of the bacterial culture into the lumen of the terminal ileum (17) . The severity of diarrheal disease in individual animals was expressed as the choleragenic score (4) . A minimum of three infant rabbits was tested with each strain, and mean choleragenic scores were used as a measure of the relative virulence for infant rabbits of parental and mutant strains of V. cholerae. Autopsies on infant rabbits were performed at the times indicated in the text. The intestinal tract from pylorus to rectum was excised and rinsed. The intestine and its contents were then minced in 25 ml of syncase broth and homogenized in an Ultra-Turrax tissue homogenizer (Tekmar Co., Cincinnati, Ohio). Appropriate dilutions of each homogenate were inoculated on meat extract agar for determination of viable counts of V. cholerae and of other aerobic bacteria from the intestinal tracts of the infected rabbits. For tests with adult rabbits, ligated ileal loops were established at laparotomy (18) , and 1-ml samples of the cultures to be tested were inoculated into the lumen of the ligated loops. The animals were sacrificed and examined 12-18 h after inoculation, and the secretory responses were expressed as milliliters of accumulated fluid per centimeter of ligated intestinal segment.
Analysis of proteins by electrophoresis in polyacrylamide gels. Formulations for sample gels and spacer gels employing a high pH discontinuous buffer system were as described by Maizel (27) . Electrophoresis was performed in a model 1,200 bath assembly (Canalco, Inc., Rockville, Md.) and the length of the sample gels was 6 cm. 100-.1u samples contained either 80-90 ,Ag of extracellular proteins from concentrated syncase broth cultures of V. cholerae or 10-,gg samples of purified choleragen or choleragenoid. Protein concentrations were determined by the method of Lowry, Rosebrough, Farr, and Randall using bovine serum albumin as the standard (28) . Electrophoresis was carried out at 4 mA/gel until the tracking dye had migrated to a position near the distal ends of the gels (approximately 1.5 h). Gels were fixed in 20%o trichloroacetic acid (TCA), stained with 0.2% Coomassie brilliant blue in 20%o TCA, decolorized with 40% ethanol, and stored in 7%, acetic acid. RESULTS V. cholerae 569B Inaba and 3083-2 Ogawa are virulent strains capable of producing cholera in man and experimental animals. Both strains produce choleragen in vitro in syncase broth cultures. They are both prototrophic and grow on the unsupplemented minimal medium used in these studies. Strains 569B and 3083-2 were selected as parental types for our studies on the genetic control of toxinogenesis in V. cholerae.
When strain 569B or strain 3083-2 is grown in pour Table I ). After treatment with EB only two haloless colonies were found among 6,629 scorable colonies (experiments 8 and 9, Table I ). Because of this low frequency, it is not certain whether they were induced by EB or had occurred spontaneously. All haloless mutants of strain 569B formed surface colonies on meat extract agar indistinguishable from those of the parental strain 569B. In contrast, cloned cultures of strain 3083-2 contained variants at a frequency of 1% or greater that formed colonies that were more opaque in oblique transmitted light than those of the parental strain 3083-2. These morphological variants of strain 3083-2 also formed haloless colonies in antitoxin agar. Because of the high frequency of spontaneously occurring haloless mutants, chemical mutagenesis was not used with strain 3083-2.
Haloless mutants derived from strains 569B and 3083-2 were subjected to further tests in vitro to establish how the haloloess phenotype correlates with specific alterations in toxinogenesis. Several different classes of mutants were identified, and the phenotypic properties of representative mutants from each class are summarized in Table II . Specific data concerning some of the qualitative and quantitative tests used for the (10) (Table III) . Concentrated culture supernates from eight of these toxf mutants were examined by electrophoresis in polyacrylamide gels (Table III and Fig. 1 ). In the parental strains 569B and 3083-2, choleragen is the most abundant extracellular protein, although many other proteins are also present in smaller quantities. The extracellular proteins of these tox-mutants had mobilities similar to proteins that were also present in cultures of the parental strains. None of the mutants had a strongly stained protein band corresponding in mobility to choleragen or to choleragenoid. In addition, none of the mutants produced any single protein that might be a nonantigenic, electrophoretic variant of choleragen in quantities that were comparable to the amount of choleragen in cultures of the parental strains. The 10 toxF strains investigated were also separated into two groups differing in their ability to revert from tox-to tox+ (Table II) . The phenomenon of reversion to tox+ in these strains will be discussed later.
One haloless strain, M14, elaborates small amounts of extracellular enterotoxin but differs from both the parental strain 569B and from other mutants that give low yields of choleragen. The unique property of strain M14 FIGURE 2 Demonstration of extracellular and cell-associated choleragen produced by V. cholerae strains 569B and M14. Preparation of antigens is described in Methods. Wells in Ouchterlony gel-diffusion plates contained the following specimens: A1, 569B culture supernate; A2, 569B sonicated cells; B1, M14 culture supernate; B2, M14 sonicated cells; C purified choleragen, 200 utg/ml; center well, equine anticholeragenoid serum. Antigen from 569B-supernate and from M14-sonicated cells forms a line of identity with purified choleragen. A second antigen unrelated to choleragen is detected by this antiserum (10) and is responsible for the weak precipitin lines formed between the antiserum and samples A2, B1, and B2.
is that it produces large amounts of cell-associated enterotoxin, as demonstrated by immunodiffusion tests with sonicated cell extracts as antigen ( Fig. 2 and Table   III) .
Strain 3083-2 var-1 is representative of the spontaneous tox-colonial variants of strain 3083-2 that occur with high frequency (Tables II and III) . Tox+ revertants derived from 3083-2 var-1 have the colonial morphology of the parental strain 3083-2. In several successive cycles of forward and reverse mutation with derivatives of strain 3083-2, colonial morphology and toxinogenicity always changed at the same time. These properties suggest that alterations of toxinogenicity and colonial morphology in strain 3083-2 may be pleiotropic effects of a single mutation.
Eight of the toxe mutants in Table III that produced no detectable choleragen with the most sensitive immunological tests used in vitro were examined for choleragenicity in experimental animals. Data derived from intraintestinal infection of infant rabbits by the tox+ parental and tox-mutant strains of V. cholerae 569B and 3083-2 are summarized in Table IV . In these experiments large inocula of living vibrios, between 108 and 109 per infant rabbit, were used to provide a sensitive test for virulence. Animals that died were autopsied at 18-24 h postinfection, and survivors were sacrificed and autopsied at 48 h postinfection. The wild type tox+ strains 569B and 3083-2 produced fatal infections in all animals within 24 h, and the mean cho-leragenic scores with these strains were above 8. In contrast, all of the toz-mutants were less virulent than the parental strains. None of the rabbits succumbed to infection with any of the toxz mutants in 48 h. Strains M13 and M27 were totally avirulent and produced no signs of diarrheal illness in any of the infected animals. In contrast, other strains like M5 and M37 produced mild diarrheal disease and had mean cholerangenic scores less than 4.
Quantitative bacterial counts were performed after excision and homogenization of the intestines and their contents obtained at autopsy from the infected infant rabbits. Cholera vibrios were present and easily cultured from all specimens. In most cases they constituted the major component of the cultivable aerobic intestinal microflora. The total numbers of vibrios recovered per intestine were usually greater than 109 with the tox+ parental strains, but with the tox-avirulent mutant M13 the total counts varied between 106 and 109. The tox~mutants that produced mild disease were usually recovered from infant rabbits in larger numbers than found with strain M13. Selected colonies of V. cholerae isolated from each infected rabbit were examined by slide agglutination to verify their serotypes and were tested to determine their ability to produce choleragen. All colonies tested from animals infected with the avirulent strains M13 and M27 were toxt. In contrast, a significant proportion of the vibrios recovered from rabbits infected with strains that produced mild diarrheal illness were found to be tox+. When control cultures of the toxe strains were tested for the presence of tox. revertants without passage in infant rabbits, none were detected. Passage of tox-mutants of V. cholerae in infant rabbits therefore provides a selective environment for growth of tox? revertants. The tox mutants M13 and M27 were also tested in ileal loops in adult rabbits. No secretory response was elicited with either mutant strain, although controls with the parental strain 569B were strongly positive (2.2-2.4 ml/cm). After culture from the contents of the infected intestinal loops, 200 colonies of M13 and 100 colonies of M27 were tested for enterotoxin production on Elek plates, and none was positive. Among 100 colonies of V. cholerae recovered from loops infected with the parental strain 569B, all gave positive tests for enterotoxin. Based on all of our experiments to date, including 26 ileal loop tests with M13 and 4 tests with M27 in addition to the studies with infant rabbits described above, these mutants appear to be stable and nonreverting toxz strains of V. cholerae.
Several experiments were performed to compare colonization of infant rabbits by the virulent parental strain 569B and by the stably toxe-avirulent mutant M13 (Table V) . Inocula of 4.8 X 10' viable cells of 569B multiplied to yield an average of 6.1 X 109 progeny and produced severe diarrheal disease in all infant rabbits. In contrast, inocula of 3.8 X 1OW-3.8 X 10' viable cells of M13 produced no signs of illness in any rabbit, although strain M13 multiplied and persisted in the intestinal tract for at least 48 h after inoculation. The numbers of vibrios recovered from the intestines of animals infected with M13 were smaller than from animals infected with the parental strain 569B. To determine whether or not the development of a secretory diarrhea facilitates colonization of the intestinal IV of V. cholerae in the Infant Rabbit Model tract by nontoxinogenic strains of V. cholerae, 2-5 ,lg of purified choleragen was administered to infant rabbits intragastrically in buffer 1 h before the rabbits were infected intraintestinally with various inocula of mutant M13 (Table V) . All animals became colonized, and there were no striking or consistent differences in the numbers of M13 recovered at autopsy from animals pretreated with choleragen and from animals pretreated with buffer alone. (3) . Under various conditions it can be dissociated into subunits that are not identical (29, 30) . Unless the subunits are formed by cleavage of a single polypeptide chain, separate structural genes must be required for the synthesis of each district polypeptide subunit of the choleragen molecule. In addition, detectable yields of choleragen are formed in some but not in all media that support the growth of V. cholerae 569B or 3083-2, and other strains of V. cholerae may differ in their requirements for optimal production of enterotoxin in vitro (1, 31) . Because choleragen is not formed constitutively by tox+ strains of V. cholerae, it is likely that specific regulatory systems control the synthesis and secretion of choleragen in a manner that is distinct from the regulation of bulk protein synthesis.
Studies on Toxinogenesis in lVibrio cholerae
Recent evidence suggests that production of choleragen by V. cholerae may be regulated by mechanisms that require cyclic AMP (32) . If the above observations are interpreted by analogy with other well-studied bacterial systems (33) , the control of toxinogenesis in V. cholerae should involve coordinated interactions of two or more structural genes with specific regulatory genes and sites (repressors, operators, promotors, etc.) that determine the production and expression of positive or negative regulatory products.
Our independently isolated mutants of V. cholerae with altered toxinogenicity could be separated into groups with different phenotypic properties (Tables II  and III, Figs. 1 and 2) . The mutants that we have designated tox make no choleragen detectable in vitro by precipitin test or by electrophoresis in polyacrylamide gels. Supernates of mutant M13 concentrated 100-fold also gave no reactions in Ouchterlony tests (unpublished observations) with antisera specific for the immunologically noncross-reacting subunits A and B of choleragen described recently (31) . Taken together, these data suggest that none of the structural genes required for synthesis of choleragen is expressed in our toxz mutants and indicate that such structural genes may be coordinately regulated. It is possible, therefore, that the toxe phenotypes of our mutant strains could reflect either mutations in regulatory genes or mutations in structural genes that have strong polar effects.
We have previously described an antigenic difference, detected by an immunological cross-reaction in precipitin tests, between the enterotoxins of strains 569B and 3083-2 (10). It may be possible, therefore, to use this antigenic difference as a marker for a structural gene for choleragen in genetic studies with strains 569B and 3083-2 of V. cholerae. The observation that toxinogenesis and colonial morphology are altered simultaneously by single mutations in V. cholerae 3083-2 could be explained either by coordinate regulation of tox with other genes controlling colonial morphology or by some biochemical activity of choleragen required for normal colonial morphology in strain 3083-2.
The other mutants described in the present studies have phenotypes that suggest the alteration of specific regulatory functions that control toxinogenesis in V. cholerae. Some mutants like Ml (Tables II and III) make detectable yields of antigenically normal and biologically active choleragen, indicating that the structural genes for choleragen are intact. Strains like these that make reduced yields of choleragen under optimal conditions of cultivation might harbor mutations in promotors or mutations that produce polar effects.
Strains like M14 (Tables II and III) , that synthesize intracellular choleragen but produce small yields of extracellular toxin, may be altered in specific functions associated with the secretion of choleragen. Although the precise localization of the cell-associated choleragen in strain M14 is not established, the fact that it is released by sonication to a form that is freely detectable in immunodiffusion experiments suggests that it is located within the cell or its periplasmic space rather than absorbed nonspecifically to the external surface of the bacterial cell. Physiological studies of strains like M14 might therefore elucidate processes of general biological significance for the secretion of specific extracellular enzymes, proteins, or toxins in bacteria.
Although the hypotheses described above provide plausible explanations for the properties of the mutants we have observed, there are no direct data at present to confirm these or to exclude alternative formulations. Nevertheless, such hypotheses can be subjected to experimental tests by formal genetic studies, since the various genetic elements have specific properties that have been defined in other systems. A conjugal mating system exists in V. clolerae and is dependent on a sex factor designated P that is analogous in many respects to the classical fertility factor F of E. coli (15, 34) . Mapping of chromosomal genes that determine nutritional requirements, antibiotic resistance, and surface antigens in V. cholerae were begun by Bhaskaran and his colleagues (14, 15) and extended by Parker, Gauthier, and Romig (35) and Parker, Tate, Richardson, Gauthier, and Romig (36) . It should therefore be feasible to apply the techniques of formal genetics to the analysis of our mutants of V. cholerae with altered toxinogenicity. In addition, studies in our laboratories with tox-strains of V. cholerae unrelated to the mutants described here have demonstrated that genes controlling toxinogenesis can be transferred by conjugation and have established that one such gene is located on the chromosome of V. cholerae.2 Thus, regulation of toxinogenesis in V. cholerae may differ from the plasmid-mediated system for control of enterotoxin synthesis reported in E. coli (13) .
Our observations on the virulence of mutants of V.
cholerae in experimental animals (Tables IV and V) (3) . Immunological responses of animals to infection with mutants of V. cholerae altered in toxinogenicity are of considerable interest but were not included in the studies reported here because the animal systems used were short-term, terminal models. The idea that attenuated strains of V. cholerae isolated from nature (37) or developed in the laboratory (38) (39) (40) might be useful as live vaccines is not new. For several reasons, however, the strains we have isolated offer advantages over strains used by previous investigators for such experimental studies of immunization against cholera. Our tox-mutants are prototrophic and are antigenically similar to the parental strains. They appear to differ from the parental strains only in toxinogenicity. They can also multiply in the intestines of infected animals and are capable of colonizing the intestinal tract. Toxt strains like M13 are totally avirulent and have not been observed to revert to tox+. Such tox-strains may therefore be able to elicit antibacterial immunity to cholera in appropriately infected experimental animals. Attempts to isolate stably toxstrains that produce immunologically cross-reacting but biologically inactive choleragen have not yet been successful, but such mutants would also be of even greater interest as possible vaccine strains.
